Direxion Daily S&P Biotech Bull 3X Shares LABU
Set alert
247.22 USD -9.74 -3.79%
At close
249.99 +2.77 +1.12%
Pre-market · Nov 2, 6:31 AM ET
239.28 Day range 264.75
108.90 52-week range 341.93
- YTD
- +55.10%
- 1 year
- +88.65%
- Open
- 251.50
- Prev close
- 256.96
- Mkt cap
- 1.32B
- Vol
- 298.06K
- Avg vol
- 398.38K
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 239.28
- High
- 264.75
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 262.35
- 200-d avg
- 216.17
- 1y target
- 0.00
30m chart
Built from the cached five-day intraday bars.
Signals (13)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 3:55 PM | 2 days ago |
| SMA: Bearish | Oct 30, 10:25 AM | 2 days ago |
| SMA: Bearish | Oct 30, 9:55 AM | 2 days ago |
| SMA: Bullish | Oct 29, 3:55 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:25 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 12:25 PM | 3 days ago |
| RSI: Overbought | Oct 29, 11:25 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 10:25 AM | 3 days ago |
| RSI: Overbought | Oct 28, 3:55 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:25 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:55 PM | 4 days ago |
| RSI: Overbought | Oct 27, 3:55 PM | 5 days ago |
| SMA: Bullish | Oct 26, 3:55 PM | 6 days ago |
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 262.35
- 200-day average
- 216.17
Analyst view
Price target (mean) 0.00
Next earnings
Consensus EPS estimate 0.00.
About Direxion Daily S&P Biotech Bull 3X Shares
The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on LABU — it syncs with the Stock Master app.